Macrophages and tumor angiogenesis

Leukemia

Volumn 21, Issue 10, 2007, Pages 2085-2089

  Ribatti, D ^a   Nico, B ^a   Crivellato, E ^b   Vacca, A ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN RECEPTOR; CD14 ANTIGEN; CD34 ANTIGEN; CELL ADHESION MOLECULE; COLECALCIFEROL; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; CORTICOSTEROID; CYTOKINE; CYTOKINE RECEPTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MATRILYSIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN; RANTES; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; BASOPHIL; BLADDER CARCINOMA; BREAST CANCER; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INFILTRATION; CELL INTERACTION; CELL STRUCTURE; CELL TYPE; CHEMOTAXIS; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE FREE SURVIVAL; EDITORIAL; ENDOTHELIUM CELL; EOSINOPHIL; ESOPHAGUS CARCINOMA; EXTRACELLULAR MATRIX; FIBROBLAST; GLIOMA; HOST CELL; HUMAN; HYPOXIA; IMMUNE RESPONSE; INFLAMMATORY CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MALIGNANT NEOPLASTIC DISEASE; MAST CELL; MELANOMA; METASTASIS POTENTIAL; MICROENVIRONMENT; MONOCYTE; MONONUCLEAR CELL; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; OVERALL SURVIVAL; PERICYTE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SQUAMOUS CELL CARCINOMA; STROMA CELL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR VASCULARIZATION;

EID: 34548744027     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404900     Document Type: Editorial

References (91)

1. Ribatti D, Vacca A, Dammacco F. The role of vascular phase in solid tumor growth: A historical review. Neoplasia 1999; 1: 293-302.
2. Vacca A, Ribatti D. Bone marrow angiogenesis in multiple myeloma. Leukemia 2006; 20: 193-199.
3. Ribatti D, Nico B, Crivellato E, Roccaro AM, Vacca A. The history of the angiogenic switch concept. Leukemia 2007; 21: 44-52.
4. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889; i: 571-573.
5. Ribatti D, Mangialardi G, Vacca A. Stephen Paget and the 'seed and soil' theory of metastatic dissemination. Clin Exp Med 2006; 6: 145-149.
6. Ross JA, Auger MJ. The biology of the macrophage. In: Nurke B, Lewis CE (eds), The Macrophage, 2nd edn. Oxford University Press: Oxford, 2002, pp 45-77.
7. Tauber AI, Chernyak L. Metchnikoff and the Origins of Immunology: From Metaphor to Theory. Monographs on the History and Philosophy of Biology. Oxford University Press: New York, 1991, pp 1-155.
8. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. Eur J Cancer 2006; 42: 717-727.
9. Virchow R. Die Krankenaften Geschwulste. August Hirschwald: Berlin, 1863, pp 1-255.
10. Dvorak HF. Tumors: Wounds than not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-1659.
11. Graves DT, Valente AJ. Monocyte chemotactic proteins from human tumor cells. Biochem Pharmacol 1991; 41: 331-337.
12. Bottazzi B, Polentarutti N, Acero R, Balsari A, Boraschi D, Ghezzi P et al. Regulation of the macrophage content of neoplasms by chemoattractants. Science 1983; 220: 210-212.
13. Matsushima K, Larsen CG, Dubois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1999; 169: 1485-1490.
14. Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J, Leonard EJ. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 1989; 169: 1449-1459.
15. Marumo T, Schini-Kert VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappa B and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999;48 1131-1137.
16. Lakshminarayanan V, Lewallen M, Frangogiannis NG, Evans AJ, Wedin KE, Michael LH et al. Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia. Am J Pathol 2001; 159: 1301-1311.
17. Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K et al. Significance of macrophages chemoattractant protein-1 in macrophage recruitment, angiogenesis and survival in human breast cancer. Clin Cancer Res 2000; 6: 3282-3289.
18. Goede V, Brogelli L, Ziche M, Augusting HG. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 1999; 82: 765-770.
19. Bingle L, Brown NJ, Lewis CE. The role of tumor-associated macrophages in tumor progression: Implications for new anticancer therapies. J Pathol 2002; 196: 254-265.
20. Varney ML, Olsen KJ, Mosley RL, Bucana CD, Talmadge JE, Singh RK. Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: A paracrine role of tumor-associated macrophages in tumor angiogenesis. In Vivo 2002; 16: 471-477.
21. Liss C, Fekete MJ, Hasina R, Lam CD, Lingen MW. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer 2001; 93: 781-785.
22. Locati M, Deuschle U, Massardi ML, Martinez FO, Sironi M, Sozzani S et al. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and the lipopolysaccharide in human monocytes. J Immunol 2002; 168: 3557-3562.
23. Aznenshtein E, Luboshits G, Shina S, Neumark E, Shabbazian D, Weil M et al. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res 2002; 62: 1093-1102.
24. Dorsch M, Hock H, Kunzendorf U, Diamantstein T, Blankenstein T. Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression. Eur J Immunol 1993; 23: 186-190.
25. Heike Y, Sone S, Yano S, Seimiya H, Tsuruo T, Ogura T. M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophagemediated cytotoxicity. Int J Cancer 1993; 54: 851-857.
26. Lin EY, Nguyen AV, Russell RG, Polard JW. Colony-stimulating factor-1 promotes progression of mammary tumors to malignancy. J Exp Med 2001; 193: 727-740.
27. Kacinski BM. CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med 1995; 27: 79-85.
28. Tang R, Beuvon F, Ojeda M, Mossseri V, Pouillart P, Lidereau R. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 1994; 86: 120-126.
29. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC et al. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172: 1535-1545.
30. Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA, Harris AL. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 2000; 190: 430-436.
31. Baird A, Mormeède P, Bohlen P. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun 1985; 126: 358-364.
32. Joseph-Silverstein J, Moscatelli D, Rifkin DB. The development of quantitative RIA for basic fibroblast growth factor using polyclonal antibodies against the 157 amino acid form of human bFGF. The identification of bFGF in adherent elicited murine peritoneal macrophages. J Immunol Methods 1988; 110: 183-192.
33. Matdess DK, Raines EW, Sakariassen KS, Assoian AK, Sporn MB, Bell GI et al. Induction of transforming growth factor-α in activated human alveolar macrophages. Cell 1988; 53: 285-293.
34. Rappolle DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-α and other growth factors in vivo: Analysis by mRNA phenotyping. Science 1988; 241: 708-712.
35. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Matdes DK, Raines EW et al. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987; 84: 6020-6024.
36. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992; 3: 211-220.
37. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nusier N. Macrophages-induced angiogenesis is mediated by tumor necrosis factor-α. Nature 1987; 320: 584-588.
38. Roberts NJ, Prill Jr AH, Mann TN. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitory activity. J Exp Med 1986; 163: 511-519.
39. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, Di Petro LA, Elner VM et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-1801.
40. Seo KH, Ko HM, Choi JH, Jung HH, Chun YH, Choi IW et al. Essential role for platelet-activating factor-induced NF-κB activation in macrophage-derived angiogenesis. Eur J Immunol 2004; 34: 2129-2137.
41. Martinet Y, Bitterman PB, Mornex JF, Grotendorst GR, Martin GR, Crystal RG. Activated human monocytes express the c-sis protooncogene and release a mediator showing PDGF-like activity. Nature 1986; 319 158-160.
42. Sullivan R, Gans PJ, Mc Carroll LA. The synthesis and secretion of granulocyte-monocyte colony-stimulating activity (CSA) by isolated human monocytes: Kinetics of the response to bacterial endotoxin. J Immunol 1982; 130: 800-807.
43. Hotchkiss KA, Ashton AW, Klein RS, Lenzi ML, Zhu GH, Schwartz EL. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res 2003; 63: 527-533.
44. Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev 2002; 13: 143-154.
45. Di Pietro LA, Polverini PJ. Angiogenic macrophages produce the angiogenic inhibitor thrombospondin-1. Am J Pathol 1993; 143 678-684.
46. Inoue Y, Najkayama Y, Mingawa N, Katsuki T, Nagashima N, Matsumoto K et al. Relationship between interleukin-12-expressing cells and antigen-presenting cells in patients with colorectal cancer. Anticancer Res 2005; 25: 3541-3546.
47. Belardelli F, Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol 2002; 23: 201-208.
48. Kerkela E, Ala-Aho R, Jeskanen L, Rechardt O, Grenman R, Shapiro SD et al. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol 2000; 114: 1113-1119.
49. Sunderkotter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factor. Pharmacol Ther 1991; 51 195-216.
50. Lewis CE, Leek R, Harris A, Mc Gee JO. Cytokine regulation of angiogenesis in breast cancer: The role of tumor-associated macrophages. J Leukoc Biol 1995; 57: 747-751.
51. Klimp AH, Hollema H, Kempinga C, van AG, de Vries EG, Daemen T. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res 2001; 61: 7305-7309.
52. Giraudo E, Inoue M, Hanahan D. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 2004; 114: 623-633.
53. Talks KL, Tyrley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000; 157: 411-421.
54. Leek RD, Landers RJ, Harris AL, Lewis CE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999; 79: 991-995.
55. White JR, Harris RA, Lee SR, Craigon MH, Binley K, Price T et al. Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics 2004; 83: 1-8.
56. Lewis JS, Landers RJ, Underwood JC, Harris AL, Lewis CE. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 2000; 192: 150-158.
57. Burke B, Giannoudis A, Corke KP, Gill D, Wells M, Ziegler-Heitbrock L et al. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxiaregulated gene therapy. Am J Pathol 2003; 163: 1233-1243.
58. Nishizuka I, Ichikawa Y, Ichikawa T, Kamiyama M, Hasegawa S, Momiyama N et al. Matrylisin stimulates DNA synthesis of cultured vascular endothelial cells and induce angiogenesis in vivo. Cancer Lett 2001; 173: 175-182.
59. Bingle L, Lewis CE, Corke K, Reed MW, Brown NJ. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 2005; 94: 101-107.
60. Evans R. Effect of X-irradiation on host cell infiltration and growth of murine fibrosarcoma. Br J Cancer 1977; 35: 557-566.
61. Evans R. The effect of azathioprine on host-cell infiltration and growth of a murine fibrosarcoma. Int J Cancer 1977; 20: 120-128.
62. Mostafa LK, Jones DB, Wright DH. Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: Studies on the chorioallantoic (CAM) of the chick embryo. J Pathol 1980; 132 91-105.
63. Mostafa LK, Jones DB, Wright DH. Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: Studies employing bovine aortic endothelial cells in vitro. J Pathol 1980; 132 207-216.
64. Stenzinger W, Bruggen J, Macher E, Sorg C. Tumor angiogenic activity (TAA) production in vitro and growth in the nude mice by human malignant melanoma. Eur J Cancer Clin Oncol 1982; 19: 649-656.
65. Polverini PJ, Leibovich SJ. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor associated macrophages. Lab Invest 1984; 51: 635-642.
66. Polverini PJ, Leibovich SJ. Effect of macrophage depletion on growth and neovascularization of hamster buccal pouch carcinomas. J Oral Pathol 1987; 16: 436-441.
67. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA et al. Macrophage regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006; 66: 11238-11246.
68. De Palma M, Venneri MA, Galli R. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005; 8: 211-226.
69. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996; 56: 4625-4629.
70. Leek RD, Harris AL. Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 2002; 7: 177-189.
71. Makitie T, Summanen P, Tarkkanen A, Kivela T. Tumor infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci 2001; 42: 1414-1421.
72. Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H et al. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 1999; 5: 1107-1113.
73. Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 2004; 99: 1667-1674.
74. Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N, Nomura Y. Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 2000; 7: 263-269.
75. Lissbrandt IF, Stattin P, Wilkstrom P, Damber JE, Egevad L, Bergh A. Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival. Int J Oncol 2000; 17: 445-451.
76. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: Tumor associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549-555.
77. Fernandez Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner N, Zuzarte ML et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 2000; 65: 287-300.
78. Rehman J, Li J, Orschell CM, March KL. Peripheral blood 'endothelial progenitor cells' are derived from monocytes/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164-1169.
79. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003; 108 2511-2516.
80. Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J et al. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res 2001; 49: 671-680.
81. Elsheikh E, Uzunel M, He Z, Holgersson J, Nowak G, Sumitran-Holgersson S. Only a specific subset of human peropheral-blood monocytes has endothelial-like functional activity. Blood 2005; 106: 2347-2355.
82. Fujiyama S, Amano K, Uehira K, Yoshida M, Nishiwaki Y, Nozawa Y et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate neoendothelization as endothelial progenitor cells. Circ Res 2003; 93: 980-989.
83. Iba O, Matsubara H, Nozawa Y, Fujiyama S, Amano K, Mori Y et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002; 106: 2019-2025.
84. Nowak G, Karrar A, Holmen C, Nava S, Uzunel M, Hultenby K et al. Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent populations capable of reendothelialization. Circulation 2004; 110: 3699-3702.
85. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 2003; 100: 2426-2431.
86. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-3427.
87. Schmeisser A, Graffy C, Daniel WG, Strasser RH. Phenotypic overlap between monocytes and vascular endothelial cells. Adv Exp Med Biol 2003; 522: 59-74.
88. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001; 104: 1046-1052.
89. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, Duan J et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001; 103: 895-897.
90. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Peer J et al. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am J Pathol 1999; 155: 739-752.
91. Scavelli C, Nico B, Cirulli T, Ria R, Di Pietro G, Mangieri D et al. Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene 2007 (accepted for publication).